Related Experiment Video
Updated: Oct 17, 2025
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.1K
The lupus nephritis management renaissance.
Juan M Mejia-Vilet1, Ana Malvar2, Arnon Arazi3
1Department of Nephrology, Instituto Nacional de Ciencas Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
Kidney International
|October 7, 2021
Summary
Two new lupus nephritis (LN) drugs were approved, prompting a reevaluation of LN management strategies. Future approaches will integrate kidney biopsies, molecular diagnostics, and biomarkers for improved patient outcomes.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- The US Food and Drug Administration approved two novel drugs for lupus nephritis (LN) treatment in the past year.
- This marks the first time specific therapies have been approved for this condition.
- The advent of these new treatments necessitates a comprehensive review of current LN management strategies.
Purpose of the Study:
- To re-evaluate the overall management strategy for lupus nephritis (LN).
- To discuss the integration of new therapeutic options into clinical practice.
- To explore the evolving role of kidney biopsies, molecular technologies, and biomarkers in LN management.
Main Methods:
- Review of recent developments in lupus nephritis (LN) treatment and diagnostics.
- Analysis of the application of molecular technologies for biopsy interrogation.
- Discussion on incorporating LN biomarkers into patient management paradigms.
Main Results:
- Two new drugs specifically for lupus nephritis (LN) have been approved.
- Emerging molecular technologies offer new ways to interrogate kidney biopsies.
- Biomarker discovery is advancing, with potential for integration into management.
Conclusions:
- The approval of new LN drugs necessitates a paradigm shift in disease management.
- Future LN management should incorporate kidney biopsies for monitoring, not just diagnosis.
- Integrating molecular data and biomarkers will personalize and optimize LN treatment strategies.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
37
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
37
01:24Nephrotic Syndrome III : Nursing Management
64
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
64
01:22Acute Kidney Injury VI: Nursing Management
115
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
115
01:28Chronic Kidney Disease III: Interprofessional Care
129
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
129
01:18Chronic Kidney Disease IV: Nursing Management
88
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
88
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
75
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
75